A University of Cambridge team used computer-designed antibodies to stop amyloid-beta plaques, a hallmark of Alzheimer's disease, from forming.
For the first time, Stanford University researchers have used a new type of whole-genome sequencing to diagnose a patient.
Scientists at Pfizer have figured out how to make blood cancer cells more vulnerable to attack—by driving them from their favorite hiding place.
European scientists tested a vaccine to inhibit the cholesterol-related enzyme PCSK9 and reported promising results in mice.
A new molecule may shed light on how synaptic imbalances happen and improve understanding of neurological conditions.
A Rutgers University-led team has discovered a new antibiotic that could work against bacteria that have developed drug resistance.
Researchers from the Washington University School of Medicine found that injecting trehalose, a naturally occurring sugar, reduced arterial plaque in mice.
Massachusetts General Hospital scientists have evidence that a TB vaccine prevents the immune system from attacking normal tissues.
British researchers kicked up some buzz at the American Society of Clinical Oncology annual meeting on June 3 with positive results from a phase 1 trial in…
German scientists have discovered a new “off-switch" for the mTor pathway, which could lead to new diabetes therapies.